Bio Details

Eric Shaff has over 15 years of experience working in leadership roles in biotechnology finance, corporate development and capital markets. Prior to Seres, he was Vice President, Corporate Finance at Momenta Pharmaceuticals, where he helped manage Momenta’s accounting, finance, planning and procurement functions, as well as contributing to Momenta’s investor relations efforts. Prior to joining Momenta, Mr. Shaff was Vice President, Finance of Genzyme’s Rare Genetic Disease Division, responsible for a global portfolio of products with annual revenue greater than $2 billion. Mr. Shaff held several positions at Genzyme in business unit finance, corporate finance as well as corporate development. Prior to Genzyme, Mr. Shaff worked in corporate finance at Pfizer, and worked in investment banking for Broadview International (now Jefferies LLC). Eric holds a B.A. from the University of Pennsylvania in political science and economics, and a M.B.A. with a concentration in finance from the Johnson Graduate School of Management at Cornell University.